Evaluating haemostatic methods for hemophilia patients with inhibitors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the effectiveness of global haemostatic methods in patients with hemophilia who have developed inhibitors to factor concentrates. It focuses on individuals who require bypassing agents for treatment, as traditional coagulation tests may not accurately monitor their response to therapy. The study will gather data on the utility of these methods in managing bleeding episodes in this challenging patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* informed consent
* meets the study population description

Exclusion Criteria:

* no informed consent age\<7 years

Where it's running

• Karolinska University Hospital
  Solna, Stockholm County, Sweden Recruiting

Study contacts

• Principal investigator: Roza Chaireti, MD, PhD — Karolinska Institutet
• Study coordinator: Roza Chaireti, MD, PhD
• Email: roza.chaireti@ki.se
• Phone: +46 738 5170974

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalized Hemophilia Care Through Telemedicine and Adherence Monitoring

  This study tests a telemedicine-based program to closely monitor bleeding, ensure patients stick to their treatment plan, and personalize care for adults with hemophilia who use a smartphone.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan · NCT07867834

• Checks how well the Figure-of-Eight Walk and Weight-Bearing Lunge tests measure movement in adults with hemophilia

  This observational study tests two movement tests to see if they reliably reflect mobility in adults with hemophilia who have a history of joint bleeding.

  Recruiting Yuzuncu Yil University · Van · NCT07851922

• Multimodal Telerehabilitation vs Face-to-Face Care for Adults with Hemophilia and Chronic Pain

  This trial tests whether a 6-week telerehabilitation program combining pain education and therapeutic exercise works as well as in-person care for adults with hemophilia and chronic pain.

  Recruiting University of Chile · Santiago, Santiago Metropolitan · NCT07682519

• PCC treatment for hemophilia A patients with inhibitors

  This trial tests whether giving prothrombin complex concentrate (PCC) during bleeding episodes can stop bleeds in people aged 12–65 with hemophilia A who have inhibitors.

  Recruiting Phase 4 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT07406139

• Fitusiran prophylaxis for boys aged 1 to under 12 with severe hemophilia A or B

  This study tests whether fitusiran given as prophylaxis can reduce bleeding in boys aged 1 to under 12 with severe hemophilia A or B, with or without inhibitors.

  Recruiting at 37 sites Phase 3 Sanofi · Los Angeles, California and 36 other locations · NCT07285460

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.